CLINICAL STUDY TO EVALUATE THE MAXIMUM TOLERATED DOSE OF BAY1000394 WHEN GIVEN TOGETHER WITH CHEMOTHERAPY AND THE EFFECTIVENESS OF THIS COMBINATION TREATMENT IN SHRINKING A SPECIFIC TYPE OF LUNG TUMORS (SMALL CELL LUNG CANCER):